Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
April 11, 2007
WASHINGTON, DC, April 11, 2007 — The Food and Drug Administration Alumni Association (FDAAA) has honored Covington’s Peter Barton Hutt with the Harvey W. Wiley Award. The award presentation took place today at the FDAAA annual meeting and was preceded by a lecture by Mr. Hutt. The Wiley award is presented annually to an individual who has made a significant lifetime contribution to the mission of the FDA. The award is named in honor of Dr. Harvey W. Wiley, the renowned physician-chemist whose leadership led to the passage of the Pure Food and Drug Act of 1906. Past winners include Donald Kennedy, former FDA Commissioner and President of Stanford, Abbey Meyers, founder and CEO of the National Organization for Rare Disorders, and Paul Rogers, former chairman of the U.S. House of Representatives Subcommittee on Health and the Environment. Mr. Hutt practices in Covington’s Washington, DC office, specializing in food and drug law. He began his law practice with the firm in 1960 and, except for four years as Chief Counsel for the FDA, has continued ever since as a longtime partner and now senior counsel. Since 1994, Mr. Hutt has taught at Harvard Law School, and he is the co-author of the leading food and drug law casebook used in law schools throughout the country. Mr. Hutt has won numerous accolades and has garnered recognition as a leader in his field. In April 2005, Mr. Hutt was presented the FDA Distinguished Alumni Award by FDA Commissioner Crawford. In May 2005, he received the Lifetime Achievement Award for research advocacy by the Foundation for Biomedical Research. Business Week referred to Mr. Hutt in June 2003 as the "unofficial dean of Washington food and drug lawyers." In naming Mr. Hutt in September 2005 as one of the eleven top food and drug lawyers, Legal Times described him as "the dean of the food-and-drug bar." He was named by The Washingtonian magazine as one of Washington's 50 best lawyers and as one of Washington's 100 most influential people; by The National Law Journal as one the 40 best health care lawyers in the United States; and by Global Counsel as the best FDA regulatory specialist in Washington, DC. Covington’s food and drug law practice, tracing to the firm's founding in 1919, covers every facet of food and drug regulatory law in the United States and Europe, including all matters within the FDA's regulatory purview, from food and cosmetics to the development of drugs and medical devices. The firm serves as general counsel or principal outside counsel to over 20 trade associations in the food and drug area and related fields. With a life sciences practice group numbering more than 150 lawyers, Covington “is one of the few firms to have developed a genuinely transatlantic full-service life sciences practice, with hubs on both the East and West Coasts of the US, and in London and Brussels,” according to Practical Law Company, which has consistently ranked Covington as the top life sciences industry and regulatory law firm in the world.